Apogem Capital LLC Meira G Tx Holdings PLC Transaction History

Apogem Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.55 - $11.25 $34,095 - $50,805	4,516 Added 6.16%	77,879 $655,000
Q2 2022 Aug 15, 2022	BUY	$6.8 - $14.23 $308,162 - $644,875	45,318 Added 161.59%	73,363 $555,000
Q1 2022 May 16, 2022	BUY	$13.42 - $23.38 $376,363 - $655,692	28,045 New	28,045 $388,000
Q4 2021 Feb 14, 2022	SELL	$12.78 - $23.74 $285,096 - $529,591	-22,308 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.73 - $16.08 $18,146 - $24,875	1,547 Added 7.45%	22,308 $294,000
Q2 2021 Aug 16, 2021	SELL	$12.85 - $16.2 $21,343 - $26,908	-1,661 Reduced 7.41%	20,761 $322,000
Q1 2021 May 14, 2021	SELL	$13.84 - $17.8 $14,255 - $18,334	-1,030 Reduced 4.39%	22,422 $324,000
Q4 2020 Feb 16, 2021	BUY	$12.4 - $17.6 $290,804 - $412,755	23,452 New	23,452 $355,000

100

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $288M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Apogem Capital LLC with notifications on news.